224 related articles for article (PubMed ID: 24498294)
1. A recombinant rabies virus encoding two copies of the glycoprotein gene confers protection in dogs against a virulent challenge.
Liu X; Yang Y; Sun Z; Chen J; Ai J; Dun C; Fu ZF; Niu X; Guo X
PLoS One; 2014; 9(2):e87105. PubMed ID: 24498294
[TBL] [Abstract][Full Text] [Related]
2. Codon optimization of G protein enhances rabies virus-induced humoral immunity.
Pei J; Huang F; Wu Q; Luo Z; Zhang Y; Ruan J; Li Y; Zhou M; Fu Z; Zhao L
J Gen Virol; 2019 Aug; 100(8):1222-1233. PubMed ID: 31259681
[TBL] [Abstract][Full Text] [Related]
3. Two potential recombinant rabies vaccines expressing canine parvovirus virion protein 2 induce immunogenicity to canine parvovirus and rabies virus.
Luo J; Shi H; Tan Y; Niu X; Long T; Zhao J; Tian Q; Wang Y; Chen H; Guo X
Vaccine; 2016 Aug; 34(37):4392-8. PubMed ID: 27449079
[TBL] [Abstract][Full Text] [Related]
4. Generation of a recombinant rabies Flury LEP virus carrying an additional G gene creates an improved seed virus for inactivated vaccine production.
Tao L; Ge J; Wang X; Wen Z; Zhai H; Hua T; Zhao B; Kong D; Yang C; Bu Z
Virol J; 2011 Sep; 8():454. PubMed ID: 21943337
[TBL] [Abstract][Full Text] [Related]
5. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z
Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157
[TBL] [Abstract][Full Text] [Related]
6. Protective antibody response of Balb/c mice to Bali rabies virus isolate propagated in BHK-21 cells.
Astawa INM; Agustini NLP; Masa Tenaya IW; Aryawiguna IPGW
J Vet Med Sci; 2018 Nov; 80(10):1596-1603. PubMed ID: 30210066
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of neurovirulence of flury rabies virus vaccine strains: importance of the polymerase and the glycoprotein R333Q mutation.
Tao L; Ge J; Wang X; Zhai H; Hua T; Zhao B; Kong D; Yang C; Chen H; Bu Z
J Virol; 2010 Sep; 84(17):8926-36. PubMed ID: 20538851
[TBL] [Abstract][Full Text] [Related]
8. An inactivated recombinant rabies CVS-11 virus expressing two copies of the glycoprotein elicits a higher level of neutralizing antibodies and provides better protection in mice.
Xue XH; Zheng XX; Wang HL; Ma JZ; Li L; Gai WW; Wang TC; Yang ST; Xia XZ
Virus Genes; 2014 Jun; 48(3):411-20. PubMed ID: 24535572
[TBL] [Abstract][Full Text] [Related]
9. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.
Shuai L; Wang X; Wen Z; Ge J; Wang J; Zhao D; Bu Z
Antiviral Res; 2017 Oct; 146():36-44. PubMed ID: 28822816
[TBL] [Abstract][Full Text] [Related]
10. Differential Host Immune Responses after Infection with Wild-Type or Lab-Attenuated Rabies Viruses in Dogs.
Gnanadurai CW; Yang Y; Huang Y; Li Z; Leyson CM; Cooper TL; Platt SR; Harvey SB; Hooper DC; Faber M; Fu ZF
PLoS Negl Trop Dis; 2015; 9(8):e0004023. PubMed ID: 26292099
[TBL] [Abstract][Full Text] [Related]
11. Expression of interleukin-6 by a recombinant rabies virus enhances its immunogenicity as a potential vaccine.
Luo J; Zhang B; Wu Y; Tian Q; Zhao J; Lyu Z; Zhang Q; Mei M; Luo Y; Guo X
Vaccine; 2017 Feb; 35(6):938-944. PubMed ID: 28089546
[TBL] [Abstract][Full Text] [Related]
12. One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus.
Wirblich C; Coleman CM; Kurup D; Abraham TS; Bernbaum JG; Jahrling PB; Hensley LE; Johnson RF; Frieman MB; Schnell MJ
J Virol; 2017 Jan; 91(2):. PubMed ID: 27807241
[TBL] [Abstract][Full Text] [Related]
13. Generation and characterization of P gene-deficient rabies virus.
Shoji Y; Inoue S; Nakamichi K; Kurane I; Sakai T; Morimoto K
Virology; 2004 Jan; 318(1):295-305. PubMed ID: 14972555
[TBL] [Abstract][Full Text] [Related]
14. A recombinant rabies virus carrying GFP between N and P affects viral transcription in vitro.
Luo J; Zhao J; Tian Q; Mo W; Wang Y; Chen H; Guo X
Virus Genes; 2016 Jun; 52(3):379-87. PubMed ID: 26957093
[TBL] [Abstract][Full Text] [Related]
15. Virus-Like Vesicles Based on Semliki Forest Virus-Containing Rabies Virus Glycoprotein Make a Safe and Efficacious Rabies Vaccine Candidate in a Mouse Model.
Zhang C; Tian Y; Chen C; Wang Z; Pei J; Lin C; Zhou M; Fu ZF; Zhao L
J Virol; 2021 Sep; 95(20):e0079021. PubMed ID: 34346765
[TBL] [Abstract][Full Text] [Related]
16. AAV-expressed G protein induces robust humoral and cellular immune response and provides durable protection from rabies virus challenges in mice.
Liu C; Li J; Yao Q; Gao Z; Cheng Y; Zhou M; Tang Y; Sun L; Dai J; Cao G; Zhang XL; Zhang R
Vet Microbiol; 2020 Mar; 242():108578. PubMed ID: 32122589
[TBL] [Abstract][Full Text] [Related]
17. Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and Filoviruses.
Willet M; Kurup D; Papaneri A; Wirblich C; Hooper JW; Kwilas SA; Keshwara R; Hudacek A; Beilfuss S; Rudolph G; Pommerening E; Vos A; Neubert A; Jahrling P; Blaney JE; Johnson RF; Schnell MJ
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S414-24. PubMed ID: 26063224
[TBL] [Abstract][Full Text] [Related]
18. Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies.
Tims T; Briggs DJ; Davis RD; Moore SM; Xiang Z; Ertl HC; Fu ZF
Vaccine; 2000 Jun; 18(25):2804-7. PubMed ID: 10812222
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of replication-deficient vesicular stomatitis virus based rabies vaccine in mice.
Park JE; Shin HJ
Vet Q; 2021 Dec; 41(1):202-209. PubMed ID: 33985418
[TBL] [Abstract][Full Text] [Related]
20. ICAM-1-based rabies virus vaccine shows increased infection and activation of primary murine B cells in vitro and enhanced antibody titers in-vivo.
Norton JE; Lytle AG; Shen S; Tzvetkov EP; Dorfmeier CL; McGettigan JP
PLoS One; 2014; 9(1):e87098. PubMed ID: 24489846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
